Dominik Höchli
Directeur/Membre du Conseil chez MOLECULAR PARTNERS AG
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Patrick Amstutz | M | 49 | 20 ans | |
Michael Tobias Stumpp | M | 52 | 20 ans | |
William Burns | M | 76 | 7 ans | |
Steven Holtzman | M | 70 | 10 ans | |
Vito Palombella | M | 61 | 4 ans | |
Agnete Brunsvik Fredriksen | M | 47 | 3 ans | |
Seth D. Lewis | M | - | 5 ans | |
Michael Vasconcelles | M | 61 | 4 ans | |
Sandipkumar S. Kapadia | M | 54 | 4 ans | |
Daniel Steiner | M | - | 13 ans | |
Baris Arican | M | - | 2 ans | |
Fernando Terrón | M | - |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | - |
Renate Gloggner | F | - | 3 ans | |
Philippe Legenne | M | - | 4 ans | |
Alexander Zürcher | M | - | 2 ans | |
Michael Pitzner | M | - | 2 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Andreas Emmenegger | M | 58 | 16 ans | |
Gwen A. Fyfe | M | 72 | 4 ans | |
Wim E. M. Mol | M | - |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | 4 ans |
Nicolas Leupin | M | 50 | 4 ans | |
Julien Gander | M | 45 | 6 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Suisse | 19 | 90,48% |
Pays-Bas | 2 | 9,52% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Dominik Höchli
- Réseau Personnel